"Concise industry news from the US pharmaceutical industry..."
New Account

The Magazine

Current Issue

Out from the shadows - Why the rapid rise of emerging markets will change the pharmaceutical world as we know it.

E-magazine
  • Previous Issues

Blog

Where our team of editors discuss what they think about the current NGP US Issues.

Marie Shields
Editor NGP US

Sizing up the future

What role will individually tailored therapies play in the pharmaceutical industry’s new business models?
01 Oct 2009

Editor's Blog

Sizing up the future

It’s common knowledge that the pharmaceutical industry is in the throes of change. The blockbuster model it has relied upon for decades is no longer viable, but what will take its place? Finding a niche area, perhaps, or going after orphan drugs, or moving into emerging markets.

No Comments

Double trouble

What will the rise of generics mean for the pharmaceutical industry? Generics are on the rise again. Thanks to President Obama’s decision to increase access to them as a way of bringing less expensive treatments to the American public, the generics star is once again in the ascendant, and their production is now nearly 100 percent of their branded rivals. What will this mean for the pharmaceutical industry? It depends on your point of view.

No Comments